Clinical Trials Browser

Phase 3 × OTHER × avelumab × Clear all

NCT03271372 2025-09-17

ADAM

Phase 3 Active not recruiting

Carcinoma, Merkel Cell

NCT02999087 2025-05-07

REACH

Phase 3 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT04637594 2025-01-15

IMAGINE

Phase 3 Active not recruiting

Carcinoma, Transitional Cell

NCT03827044 2022-10-07

POLEM

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Microsatellite Instability